germans trias i pujol hospital

Money raised will fund research projects at Germans Trias i Pujol University Hospital in Badalona

In interview for Filling the Sink, leading Catalan researcher says "evolution of virus could surprise us" 

Aim is to investigate how events in enclosed spaces can go ahead safely during pandemic

Private foundation is hosting temporary facility with 71 beds for mild covid-19 cases from Badalona's 'Can Ruti' hospital

Researchers at the Hospital Germans Trias in Badalona (Greater Barcelona) have taken an important step toward creating a vaccine for Type 1 diabetes, which currently has no cure. The discovery, published in the scientific journal 'Plos One', consists of the preparation of nanoparticles in the laboratory that, once introduced into the body, slow down the destruction of beta cells (whose primary function is to store and release insulin). With Type 1 diabetes, the body’s immune system attacks these insulin-producing cells located in the pancreas and destroys them. Currently, to combat the disease, patients must take insulin injections. In recent years, Catalonia has become a global hub for biomedical investigation, developing cutting-edge research initiatives and participating in leading international projects. With just 0.1% of the world’s population, Catalonia accounts for nearly 1% of global scientific production and attracts 2.2% of European competitive funds and 3.5% of European Research Council (ERC) grants.

Catalonia has established a reputation as a global centre of scientific excellence, pioneering research and innovative ideas. This corner of Europe, with just 0.1% of the world’s population, accounts for nearly 1% of global scientific production. The Catalan Research system, formed of 12 internationally esteemed universities, over 60 research centres, 15 world class hospitals, and almost 9,000 innovative companies, attests to the Catalonia's ambitions in science. This territory is also a magnet of international funding: with 1.5% of Europe’s population, it receives 2.2% of European competitive funds and 3.5% of European Research Council (ERC) grants. There can be no doubt that Catalonia is now a benchmark in Southern Europe, producing frontier research and punching considerably above its weight in terms of scientific contribution.  It is attracting worldwide talent and projects, and many consider it to be fast becoming the Palo Alto of biomedical research.

Christian Brander is a researcher at the IrsiCaixa AIDS Research Institute and Scientific Director of HIVACAT, the programme for the development of a HIV vaccine. He graduated from the University of Bern in 1994 with a PhD in Immunology and has spent 13 years at Harvard University focusing on cellular immunity to viral infections.

The vaccine works by re-introducing immune system cells, which have previously been extracted and modified, in order to avoid the destruction of beta cells, which are those producing insulin. The vaccine has been developed by researchers from the Germans Trias Hospital in Badalona, in Greater Barcelona. Furthermore, in February, another group of Catalan scientists announced the cure of Type 1 Diabetes in two dogs, which is the first time this has been successful in large animals. In the last few years, Catalonia and especially Greater Barcelona have become a world centre within the biomedicine sector.

According to experiments tested on mice, Catalan scientists have affirmed that the stem cells located in the human umbilical chord, which are multipotential and therefore can become different types of cells, can be used to regenerate the tissue affected by a heart attack or a stroke. Until now the only way to recover the damaged tissue was through pharmacological treatment or a heart transplant.

Staff members from Catalonia’s main hospitals, including Sant Pau, Vall d’Hebron, Clínic, Parc Taulí and Germans Trias i Pujol, carried out several protests on Wednesday. Some of these protests had already started a few days ago and might last a few days longer, such as spending the night in the hospital lobby. They are demonstrating to criticise the budget cuts affecting health centres and to defend the public healthcare system. Some of these hospitals are recognised at an international level for their top quality clinical and scientific research work.